scispace - formally typeset
D

Douglas A. Melton

Researcher at Harvard University

Publications -  299
Citations -  73978

Douglas A. Melton is an academic researcher from Harvard University. The author has contributed to research in topics: Stem cell & Cellular differentiation. The author has an hindex of 120, co-authored 291 publications receiving 70103 citations. Previous affiliations of Douglas A. Melton include Broad Institute & Fairchild Semiconductor International, Inc..

Papers
More filters
Journal ArticleDOI

Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter

TL;DR: In this paper, a simple and efficient method for synthesizing pure single stranded RNAs of virtually any structure is described, based on the unusually specific RNA synthesis by bacteriophage SP6 RNA polymerase which initiates transcription exclusively at an SP6 promoter.
Journal ArticleDOI

Core transcriptional regulatory circuitry in human embryonic stem cells.

TL;DR: Insight is provided into the transcriptional regulation of stem cells and how OCT4, SOX2, and NANOG contribute to pluripotency and self-renewal and how they collaborate to form regulatory circuitry consisting of autoregulatory and feedforward loops.
Journal ArticleDOI

A molecular mechanism for the effect of lithium on development

TL;DR: It is shown that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and a different hypothesis to explain the broad action of lithium is presented, which suggests that lithium acts through inhibition of glycogen synthase kinase-3 beta (GSK-3beta), which regulates cell fate determination in diverse organisms including Dictyostelium, Drosophila, and Xenopus.
Journal ArticleDOI

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.

TL;DR: This work introduces a method for genetic lineage tracing to determine the contribution of stem cells to a tissue of interest and suggests that terminally differentiated β-cells retain a significant proliferative capacity in vivo and casts doubt on the idea that adult stem cells have a significant role in β-cell replenishment.